J&J reportedly sought help from rivals after blood clot concerns emerged
Johnson & Johnson sought help from its three rival Covid-19 vaccine makers to look into reports of blood clots, but Pfizer and Moderna both declined, the Wall Street Journal reported on Friday, citing people familiar with the situation. Only AstraZeneca agreed, according to the WSJ. J&J also wanted to build an informal alliance with its
Continue Reading